Pharmaceutical Isolator Market Dynamics, Key Players, Outlook And Segmentation | Forecast to 2027
Pharmaceutical
Isolator Market: Information by Type (Open Isolator and Closed Isolator),
Pressure (Positive Pressure and Negative Pressure), Application (Aseptic
Isolators, Containment Isolators, Sampling/Weighing/Distribution Isolators,
Fluid Dispensing Isolators and others) End User (Hospitals, Pharmaceutical
& Biotechnology Companies, Research & Academic Laboratories and others)
and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) -
Global Forecast till 2027
Pharmaceutical Isolator Market Highlights
The Global Pharmaceutical
Isolator Market is expected to touch a
valuation of USD 32,944.3 million by 2023, as per the latest report by Market
Research Future (MRFR). The explosive growth of the pharmaceutical industry is
the primary driver of the market. Pharmaceutical isolators are imperative in
the drug manufacturing pipeline by segregating drugs from people. High use of
these systems in filling lines is expected to bolster market demand from 2018
to 2023 (forecast period).
Decontamination of aseptic
systems, mixing of toxic compounds, and multi-product manufacturing tasks of
pharmaceutical companies are other factors which can spur the pharmaceutical
isolator market growth. Strict government policies regarding safety of
employees are likely to influence the buying decisions of major drug
manufacturers in the coming years. Low operational costs of these systems on
the manufacturing process is another factor which can lead to its integration
in modern setups. Increasing demand for devices or systems which can guarantee
the potency and efficacy of drugs can positively impact the market. But the
adoption of restricted access barrier systems (RABS) can create headwinds in
its growth trajectory.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/4683
Segmentation:
The pharmaceutical isolator
market can be segmented by type, pressure, application, and end-user.
By type, the market is
segmented into open and closed isolator systems. The open system segment can
register 8.56% CAGR over the forecast period to reach a valuation of USD
20,566.3 million by 2023. Continuous development of novel compounds can
facilitate the segment’s growth. On the flip side, the closed system segment
can exhibit a modest 6.75% CAGR owing to increased protection from airborne
impurities.
By pressure, the market is
divided into positive and negative pressure isolators. The former accounted for
55.5% share in 2017 and touted to experience 8.42% CAGR over the assessment
period. On the other hand, the latter can accrue returns at 7.14% CAGR during
the same period. This can be credited to its role as a bulwark for humans
during production of toxic compounds.
Major market applications
include sampling/weighing/distribution, product containment, fluid dispensing,
aseptic filling, and others. Out of these, aseptic filling accounted for nearly
28% share of the pharmaceutical isolator market, followed by fluid dispensing
and sampling/weighing/distribution segments. The segment can touch USD 9,449.6
million by 2023 at a CAGR of 8.37% over the forecast period owing to the demand
for systems with minimal cracks or crevices. The fluid dispensing segment can
exhibit the highest CAGR of 9.94% owing to the high toxicity of novel compounds
used in drug manufacturing.
End-users in the pharmaceutical
isolator market include hospitals, pharmaceutical & biotechnology
companies, research & academic laboratories, and others. Among these, the
pharmaceuticals & biotechnology segment accounted for 45.8% market share in
2017. It is predicted to experience 8.13% CAGR over the forecast period due to
various guidelines mandated by drug regulatory agencies to ensure the safety of
workers.
Regional
Analysis:
The pharmaceutical isolator
market covers the latest trends and opportunities across Americas, Europe, Asia
Pacific (APAC), and the Middle East & Africa (MEA).
The Americas lead the global
market with 36.4% share in 2017, followed by Europe (34%) and APAC (24.7%). It
can continue its reign till 2023 owing to adoption of latest devices and
systems and sharp rise noticed in numbers of biotechnology laboratories. The
region can reach a valuation of USD 12,142.2 million by 2023 by growing at
8.08% CAGR over the assessment period.
The APAC pharmaceutical
isolator market is predicted to enjoy 8.73% CAGR during the forecast period
owing to the booming pharmaceutical sector in China and India. The high growth
is substantiated by presence of contract manufacturing organizations in these
countries and demand for generic drugs.
Competitive
Dashboard:
Prominent players operating in
the pharmaceutical isolator market include COMECER S.P.A. (Italy), Schematic Engineering
Industries (India), Fedegari Autoclavi S.p.A (Italy), MBRAUN (Germany), Robert
Bosch GmbH (Germany), NuAire Inc. (U.S.), VanRx Pharmasystems Inc. (Canada),
Getinge AB (Sweden), Gelman Singapore Pte Ltd. (Singapore), Skan AG
(Switzerland), IsoTech Design (Canada), Azbil Telstar (Spain), Hosokawa Micron
Ltd. (U.K.), and LAF Technologies Pty Ltd. (Australia).
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/pharmaceutical-isolator-market-4683
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
I Like to add one more important thing here, The Pharmaceutical Isolator Market is expected to be around US$ 40 billion by 2025 at a CAGR of 8% in the given forecast period.
ReplyDelete